Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
7
High Fidelity Linear MicroVector to Clone Complex, Problematic, and Large DNAs
Award last edited on: 10/11/2017
Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$224,326
Award Phase
1
Solicitation Topic Code
200
Principal Investigator
David Mead
Company Information
Varigen Biosciences Corporation
505 South Rosa Road Suite 15
Madison, WI 53719
(608) 444-9518
info@varigenbio.com
www.varigenbio.com
Location:
Single
Congr. District:
02
County:
Dane
Phase I
Contract Number:
----------
Start Date:
----
Completed:
----
Phase I year
2017
Phase I Amount
$224,326
The goal of this research is to dramatically improve the ability to clone and analyze large and unstable DNA fragments We propose to develop a novel linear cloning vector to maximize stability of cloned DNA in the bacterial host The vector will use the replication proteins of the phage Phi to achieve the highest accuracy of replication for all DNA inserts including AT rich repetitive or structurally unstable genes The cloning method will be quick and easy for DNA of any size range kb only requiring ligation of small vector arms to the DNA followed by transformation of bacteria This system will surpass existing standards for stability fidelity and lack of bias exceeding the limits of our previously developed pJAZZ linear cloning vector Importantly it will enable straightforward cloning of fosmid or BAC sized DNAs The vector will have minimal bacterial sequences providing significant benefits for mammalian cell transfection therapeutic protein production stem cell research and ultimately gene therapy The cloned DNAs will be bound to nuclear localization signals for enhanced delivery and expression in mammalian cells This Phi vector is urgently needed to help discover treatments for human illness For example the genome of the human malaria parasite Plasmodium falciparum is among the most difficult genomes to clone due to its repetitive highly AT rich nature We will collaborate with the Wellcome Trust Sanger Institute to construct and sequence long insert genomic libraries of Plasmodium falciparum This unique resource is critically needed to enable genetic research on this deadly pathogen The goal of this research is to greatly improve the ability to capture and analyze large unstable DNAs To demonstrate the usefulness of this system it will be used to clone large segments of the human malarial parasite Plasmodium falciparum an achievement that is currently impossible
Phase II
Contract Number:
----------
Start Date:
----
Completed:
----
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.